REG - Darktrace PLC - Issue & Allotment of Shares & Total Voting Rights

DarktraceAnnouncement

15/06/2023 10:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230615:nRSO8520Ca&default-theme=true

RNS Number : 8520C  Darktrace PLC  15 June 2023

15 June 2023

 

Darktrace plc

("Darktrace")

 

Issue and allotment of Shares and Total Voting Rights

Darktrace announces the issue and allotment of shares pursuant to the exercise
of options granted under the Amended and Restated Rules of the Darktrace
Limited 2013 Company Discretionary Share Option Scheme 2013. Darktrace has
issued and allotted an aggregate of 42,500 new ordinary shares of £0.01 each
in Darktrace (the "New Shares"). An application has been made for the New
Shares to be admitted to the Premium Listing Segment of the Official List of
the Financial Conduct Authority and to trading on the Main Market of the
London Stock Exchange.

The New Shares will rank pari passu in all respects with Darktrace's existing
ordinary shares of £0.01 nominal value each ("Ordinary Shares"). It is
expected that admission will become effective on 16 June 2023.

As a result of the 42,500 New Shares issued, the total number of Ordinary
Shares outstanding as at 16 June 2023 will be 707,343,308. Each Ordinary Share
carries the right to one vote. Darktrace has 3,445,905 Ordinary Shares as
treasury shares with no voting rights. Therefore as at the close of business
on 16 June 2022 the total voting rights figure of 703,897,403 may be used by
shareholders as the denominator for the calculations by which they will
determine if they are required to notify their interest in, or a change to
their interest in, Darktrace under the Financial Conduct Authority's
Disclosure Guidance and Transparency Rules.

Contact:

Luk Janssens - Head of Investor Relations, Darktrace

luk.janssens@darktrace.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCNKPBKCBKKCAD